(Q37880425)

24 August 2017

1 reference

title

New approaches to the assessment of vaccine herd protection in clinical trials (English)

1 reference

24 August 2017

1 reference

1

John Clemens

1 reference

24 August 2017

Sunheang Shin

2

1 reference

24 August 2017

Mohammad Ali

series ordinal

3

1 reference

24 August 2017

publication date

1 June 2011

1 reference

Lancet Infectious Diseases

24 August 2017

published in

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

482-487

1 reference

Vaccination and herd immunity to infectious diseases

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Measles herd immunity. The association of attack rates with immunization rates in preschool children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

A study of the sero-immunity that has protected the Swedish population against poliomyelitis for 25 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Immunization of children with pertussis toxoid decreases spread of pertussis within the family

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Diphtheria immunization. Effect upon carriers and the control of outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

The Japanese experience with vaccinating schoolchildren against influenza

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Controlling endemic cholera with oral vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

The concept of herd immunity and the design of community-based immunization programmes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Herd immunity and herd protection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Herd immunity: basic concept and relevance to public health immunization practices. 1971.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Direct and indirect effects in vaccine efficacy and effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Study designs for evaluating different efficacy and effectiveness aspects of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Immunisation and herd immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Design and analysis issues in cluster-randomized trials of interventions against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Design of a group-randomized Streptococcus pneumoniae vaccine trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Methods and measures for the description of epidemiologic contact networks

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Diarrheal disease risk in Matlab, Bangladesh.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970318-2

7 January 2021

10.1016/S1473-3099(10)70318-2

Identifiers

DOI

1 reference

24 August 2017

1 reference